Assignee
MYRIAD WOMENS HEALTH INC
US·34 granted patents·34 pending applications·73 citations·filing 2014–2025
Top patents by PatentIndex Score
68 records- 0196US12351880B2Methods of detecting and enriching circulating tumor DNAMYRIAD WOMENS HEALTH INC·Filed 2025·Granted Jul 8, 2025·2 cites·30 claims
- 0296US11932910B2Combinatorial DNA screeningMYRIAD WOMENS HEALTH INC·Filed 2021·Granted Mar 19, 2024·20 cites·14 claims
- 0395US12351879B2Enrichment of circulating tumor DNAMYRIAD WOMENS HEALTH INC·Filed 2024·Granted Jul 8, 2025·2 cites·20 claims
- 0495US12024749B2Combinatorial DNA screeningMYRIAD WOMENS HEALTH INC·Filed 2020·Granted Jul 2, 2024·8 cites·18 claims
- 0595US10597717B2Combinatorial DNA screeningMYRIAD WOMENS HEALTH INC·Filed 2017·Granted Mar 24, 2020·33 cites·11 claims
- 0694US12215392B2Methods of preparing a DNA fraction enriched with circulating tumor DNAMYRIAD WOMENS HEALTH INC·Filed 2024·Granted Feb 4, 2025·2 cites·23 claims
- 0794US12104212B2Personalized methods for detecting circulating tumor DNAMYRIAD WOMENS HEALTH INC·Filed 2023·Granted Oct 1, 2024·2 cites·18 claims
- 0893US12270082B2Methods of detecting DNA in a sampleMYRIAD WOMENS HEALTH INC·Filed 2022·Granted Apr 8, 2025·2 cites·13 claims
- 0991US12545963B1Personalized methods of detecting circulating tumor DNAMYRIAD WOMENS HEALTH INC·Filed 2024·Granted Feb 10, 2026·0 cites·20 claims
- 1090US2025122580A1Combinatorial dna screeningMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 1190US2025066862A1Laboratory execution and automation systemsMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 1288US2024150846A1Combinatorial dna screeningMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 1387US12215391B1Automated methods of detecting cell free DNAMYRIAD WOMENS HEALTH INC·Filed 2023·Granted Feb 4, 2025·0 cites·16 claims
- 1487US2026022423A1Methods of detecting and enriching circulating tumor dnaMYRIAD WOMENS HEALTH INC·Filed 2025·Application pending·0 cites
- 1585US2025095784A1Automated nucleic acid repeat count calling methodsMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 1683US12344901B2Automated methods of detecting cell free DNAMYRIAD WOMENS HEALTH INC·Filed 2022·Granted Jul 1, 2025·0 cites·15 claims
- 1783US2026035737A1Methods for identifying carrier status and assessing risk for spinal muscular atrophyMYRIAD WOMENS HEALTH INC·Filed 2025·Application pending·0 cites
- 1879US2024363195A1Systems and methods for inferring genetic ancestry from low-coverage genomic dataMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 1978US11232850B2Copy number variant callerMYRIAD WOMENS HEALTH INC·Filed 2018·Granted Jan 25, 2022·2 cites·27 claims
- 2076US10497463B2Automated nucleic acid repeat count calling methodsMYRIAD WOMENS HEALTH INC·Filed 2014·Granted Dec 3, 2019·0 cites·32 claims
- 2176US2024117343A1Methods and compositions for preparing nucleic acid sequencing librariesMYRIAD WOMENS HEALTH INC·Filed 2023·Application pending·0 cites
- 2276US2025140343A1Methods for improving minimal residual disease assaysMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 2376US2024352511A1Systems and methods for identifying and quantifying gene copy number variationsMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 2475US2022267837A1Methods for identifying carrier status and assessing risk for spinal muscular atrophyMYRIAD WOMENS HEALTH INC·Filed 2022·Application pending·0 cites
- 2575US2026009073A1Noninvasive prenatal diagnostic methodsMYRIAD WOMENS HEALTH INC·Filed 2025·Application pending·0 cites
- 2674US2025137038A1Sensitivity and estimation of tumor-informed minimal residual disease panelsMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 2773US12033722B2Systems and methods for inferring genetic ancestry from low-coverage genomic dataMYRIAD WOMENS HEALTH INC·Filed 2022·Granted Jul 9, 2024·0 cites·20 claims
- 2873US2022333188A1Methods and compositions for enrichment of target polynucleotidesMYRIAD WOMENS HEALTH INC·Filed 2022·Application pending·0 cites
- 2972US2025140346A1Sensitivity of tumor-informed minimal residual disease panelsMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 3072US2021396776A1High-throughput sample processing systems and methods of useMYRIAD WOMENS HEALTH INC·Filed 2021·Application pending·0 cites
- 3171US12080383B2Automated nucleic acid repeat count calling methodsMYRIAD WOMENS HEALTH INC·Filed 2019·Granted Sep 3, 2024·0 cites·21 claims
- 3271US2022254443A1System and methods for detecting genetic variationMYRIAD WOMENS HEALTH INC·Filed 2022·Application pending·0 cites
- 3370US12534719B2Nucleic acid sequencing adapters and uses thereofMYRIAD WOMENS HEALTH INC·Filed 2023·Granted Jan 27, 2026·0 cites·25 claims
- 3468US2022396785A1Enrichment of cell-free dna from a biological sampleMYRIAD WOMENS HEALTH INC·Filed 2022·Application pending·0 cites
- 3568US2020392569A1Methods for identifying carrier status and assessing risk for spinal muscular atrophyMYRIAD WOMENS HEALTH INC·Filed 2020·Application pending·0 cites
- 3668US2024194293A1Noninvasive prenatal screening using dynamic iterative depth optimizationMYRIAD WOMENS HEALTH INC·Filed 2023·Application pending·0 cites
- 3767US11339431B2Methods and compositions for enrichment of target polynucleotidesMYRIAD WOMENS HEALTH INC·Filed 2020·Granted May 24, 2022·0 cites·20 claims
- 3866US2025013960A1Systems and methods for automatically generating genetic risk assessmentsMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 3966US2024203521A1Evaluation and improvement of genetic screening tests using receiver operating characteristic curvesMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 4064US12416003B2Methods and compositions for enrichment of target polynucleotidesMYRIAD WOMENS HEALTH INC·Filed 2021·Granted Sep 16, 2025·0 cites·14 claims
- 4164US11326158B2Enrichment of cell-free DNA from a biological sampleMYRIAD WOMENS HEALTH INC·Filed 2019·Granted May 10, 2022·0 cites·19 claims
- 4263US12265096B2Reagent delivery and waste management systemMYRIAD WOMENS HEALTH INC·Filed 2021·Granted Apr 1, 2025·0 cites·13 claims
- 4363US11527304B2Systems and methods for inferring genetic ancestry from low-coverage genomic dataMYRIAD WOMENS HEALTH INC·Filed 2019·Granted Dec 13, 2022·0 cites·21 claims
- 4462US11820980B2Methods and compositions for preparing nucleic acid sequencing librariesMYRIAD WOMENS HEALTH INC·Filed 2020·Granted Nov 21, 2023·0 cites·12 claims
- 4561US11085943B2High-throughput sample processing systems and methods of useMYRIAD WOMENS HEALTH INC·Filed 2017·Granted Aug 10, 2021·0 cites·6 claims
- 4659US12586663B2Copy number variant callerMYRIAD WOMENS HEALTH INC·Filed 2021·Granted Mar 24, 2026·0 cites·13 claims
- 4759US10968447B2Methods and compositions for enrichment of target polynucleotidesMYRIAD WOMENS HEALTH INC·Filed 2018·Granted Apr 6, 2021·0 cites·26 claims
- 4857US12416047B2Noninvasive prenatal diagnostic methodsMYRIAD WOMENS HEALTH INC·Filed 2017·Granted Sep 16, 2025·0 cites·31 claims
- 4957US2025137064A1Use of multi-nucleotide and structural variants for improved sensitivity and specificity of circulating tumor dna assaysMYRIAD WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 5056US2026092314A1Rna-facs for rare cell isolation and detection of genetic variantsMYRIAD WOMENS HEALTH INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MYRIAD WOMENS HEALTH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →